Driving forward medical device development

2 Oct 2019, 4:57 p.m.

medical devices workshop

The NIHR GOSH BRC last month hosted an inaugural medical devices workshop, in partnership with the UCL Institute of Healthcare Engineering. 80 attendees, including clinicians and researchers at various career stages, came along to hear about the entire process of medical device development from inception of an idea to eventual implementation into the patient care pathway.

During a showcase session researchers introduced attendees to a range of devices that have been developed or are being developed at GOSH and UCL, explaining their development process and sharing tips and best practice. Exemplar projects highlighted include the FizzyO project and the GOSH DRIVE App developmemt

The sessions aiming to provide researchers with practical advice on how to navigate the complex process of device development an included talks on  from patents and design rights (led by William Burrel, Patent Attorney, D Young & Co) and new product regulations (led by Dr Alan McLeod, Managing Director, Health Innovation Support Limited).

There were also introductions from teams at NIHR, the UCL Translational Research Office, UCL Institute of Healthcare Engineering, NIHR, Medicines and Healthcare Products Regulatory Agency (MHRA), UCL Business and UCL Partners, who each outlined how their organisations can support clinicians and scientists in the development of medical devices.

The event brought also provided plenty of opportunity for networking between together clinicians and scientists with unmet medical needs problems, and engineers with the technical knowledge to help develop solutions.

This event was part of the NIHR GOSH BRC’s Translational Research and Enterprise Accelerator theme which builds on the BRC's extensive track record of clinical impact through translational innovation and aims to ensure research is rapidly translated into direct benefits for children at GOSH and worldwide.

Young people donate tissue samples to unlock mysteries of arthritis

A new groundbreaking study led by researchers at the University of Birmingham, Great Ormond Street Hospital, University College London and Birmingham Children’s Hospital has revealed important clues into what is driving arthritis in children.

Toddler doing well after receiving newest gene therapy available on NHS

A toddler with a life-limiting and life-threatening rare disease is the youngest to be treated with the newest gene therapy available on the NHS at GOSH.

Genes may help to predict which children will respond well to arthritis treatment

A team of researchers at Great Ormond Street Hospital (GOSH) and University College London (UCL) have identified a set of genes that could be used to help doctors predict which children will respond well to treatment for juvenile idiopathic arthritis.

Making it easier to invest in frontline care

GOSH and UCL have signed a landmark agreement to simplify the commercialisation of any joint research and innovation and ensure any financial proceeds are shared equally.